MBRX - Moleculin Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
50.3M
Enterprise Value 3
32.55M
Trailing P/E
N/A
Forward P/E 1
-2.56
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
2.65
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
-1.93

Trading Information

Stock Price History

Beta (3Y Monthly) 1.97
52-Week Change 3-25.00%
S&P500 52-Week Change 316.03%
52 Week High 33.1500
52 Week Low 30.7770
50-Day Moving Average 31.0636
200-Day Moving Average 31.1427

Share Statistics

Avg Vol (3 month) 3179.72k
Avg Vol (10 day) 3196.55k
Shares Outstanding 545.73M
Float 34.76M
% Held by Insiders 123.73%
% Held by Institutions 111.23%
Shares Short (Oct 31, 2019) 41.93M
Short Ratio (Oct 31, 2019) 411.93
Short % of Float (Oct 31, 2019) 47.04%
Short % of Shares Outstanding (Oct 31, 2019) 44.28%
Shares Short (prior month Sep 30, 2019) 42.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-41.54%
Return on Equity (ttm)-71.84%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -16.86M
Net Income Avi to Common (ttm)-12.19M
Diluted EPS (ttm)-0.3370
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.41M
Total Cash Per Share (mrq)0.34
Total Debt (mrq)404k
Total Debt/Equity (mrq)2.13
Current Ratio (mrq)1.67
Book Value Per Share (mrq)0.41

Cash Flow Statement

Operating Cash Flow (ttm)-15.63M
Levered Free Cash Flow (ttm)-3.57M